AMED:F:F-Amundi Index Solutions - Amundi ETF MSCI EMU ESG Leaders Select (EUR)

ETF | Others |

Last Closing

USD 290.8

Change

+2.35 (+0.81)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-11 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

N/A

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.72 (-1.39%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

+2.08 (+0.35%)

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.76 (-1.34%)

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.47B
VUSA:F Vanguard Funds Public Limited ..

+0.39 (+0.36%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.58 (+0.54%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.70 (-0.29%)

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

-0.03 (-0.34%)

USD 40.89B
0ZC:F Zscaler Inc

+8.14 (+4.36%)

USD 37.92B

ETFs Containing AMED:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.61% 42% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.61% 42% F 55% F
Trailing 12 Months  
Capital Gain 12.30% 44% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.30% 44% F 54% F
Trailing 5 Years  
Capital Gain 33.21% 62% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.21% 62% D 64% D
Average Annual (5 Year Horizon)  
Capital Gain 10.98% 75% C 69% C-
Dividend Return 10.98% 73% C 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.03% 41% F 77% C+
Risk Adjusted Return 73.09% 79% B- 84% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.